Healthcare
Spending bottom dollar: Valuation gaps take Q1 buyout levels back to 2009
Sponsors make just 95 buyouts in Europe in the first quarter - a figure not seen since Sony sold 12m floppy discs in one year
PE roll-up strategies face regulatory heat with focus on consumer industries
With longer holding periods facilitating more bolt-ons, regulators including the UK's CMA are intervening
GP Profile: Metric Capital confident of structured capital strategy demand with multiple exits in pipeline
UK-based sponsor banks on appeal of its strategy as an alternative to private equity and debt providers
KKR holds USD 8bn European Fund VI buyout fund close with 12.5%-plus GP commitment
European Fund VI will deploy equity tickets of EUR 250m-750m in six core sectors
ECI reaps 2.7x return on 4ways sale to EQT-backed Evidia
Sale process for UK-based teleradiology platform had been running since September 2022
VC Profile: Target Global assesses B2B opportunities in final stretch of current fund deployment
Nearing full deployment for its second growth fund, pan-European VC firm outlines plans to back defensive B2B models and institutionalise its co-investment strategy and LP base
Large-cap sponsors circle Qiagen bioinformatics arm ahead of indicative bids
Potential PE bidders are assessing performance and market share of the Netherlands-headquartered business
Riverside acquires Dastex and Vita Verita
Sponsor plans to pursue a buy-and-build strategy for new European clean room contamination control group
EQT closes LSP Dementia on EUR 260m hard cap
Series A-focused fund exceeded its EUR 100m target and extended fundraising after increased LP interest in its strategy
Newton Biocapital heads for year-end close for second, EUR 150m life sciences fund
Belgian-Japanese VC has raised EUR 50m to date and is lining up exits from its debut fund
Sofinnova launches digital medicine strategy
Life sciences sponsorтs sixth strategy will deploy EUR 2m-EUR 8m tickets in seed and Series A
Cinven's indicative EUR 10 per share Synlab bid seen as below fair value
Sponsor listed the laboratory testing service provider at EUR 18 per share in 2020
Synova's Clyde Munro exit parked in waiting room
Dental clinic sale could resume with improved macro conditions and after post-acquisition trasing plays out
GP Profile: BGF to deploy GBP 500m-plus per year for minority growth deals with entrepreneurs
UK and Ireland-based growth investor remains committed to filling a market gap for founders who want flexibility and control
European sponsors sidestep panic, concede gloom over bank woes
Fallout from Credit Suisse collapse adds to slew of macroeconomic challenges for PE dealmaking and fundraising
Keyhaven eyes Q4 2023 fund launch amidst lower mid-market GP-leds boom
Secondaries firm looks ahead to fourth fund; sweet spot of EUR 50m-100m for deals but can go up to EUR 500m
Nordic picks Jefferies for upcoming Sunrise Medical auction
German wheelchair specialist was acquired in 2015 and moved to a continuation fund in 2018
AnaCap exits Oona Health in EUR 302m sale to Topdanmark
Deal for Danish health insurance provider generates a 4x money multiple and 40% IRR
Afinum nears EUR 410m-EUR 420m fund close; mulls new fundraise
Plans for Fund 10 to be contemplated by mid-2024 “at the earliest” as GP advances on succession changes
Women in VC: Turenne Santé's Chaoui on new healthcare growth strategy and social impact
Healthcare sponsor aims to raise EUR 150m for new growth fund, with further deployment and fundraising for its LBO strategy in the pipeline
Gyrus Capital explores Essential Pharma sale via Rothschild
UK-based specialty pharma group expected to be marketed off around GBP 70m EBITDA
Unquote Private Equity Podcast: What's next for ESG – Fedrigoni case study
Harriet Matthews is joined by colleague William Cain to discuss ESG investing amid macro clouds and interviews Bainтs Ivano Sessa about the sustainability strategy for one of the sponsor's portfolio companies
Permira raises EUR 16.7bn for Fund VIII, 50% up on previous vintage
Final close comes in a market largely devoid of multi-billion fundraises from European managers in recent months
Glass ceiling shows first cracks in PE space
Greater focus on investment team gender equality and mentoring has shifted the balance, but room for progress remains